Why Is PULSE BIOSCIENCES IN (PLSE) Stock Up Today?

Why PLSE stock is up today

PLSE stock rose 8.26% to $32.76 in intraday trading as the company announced a key business update and scheduled its second quarter 2026 financial results conference call for August 6, 2026. The call is set for 1:30 p.m. PT after the market close, with a live and recorded webcast available on the company’s investor website. This development has driven investor interest in the stock.

What Happened

Pulse Biosciences has scheduled a conference call to discuss its second quarter 2026 financial results. The call will include business updates and will be accessible via a live and recorded webcast. The timing of the announcement, combined with recent insider activity and a recent earnings beat, has contributed to the stock’s positive movement. Additionally, the CEO and a director of the company purchased shares totaling $13.3 million via an ATM program on May 11, 2026.

What The Data Shows

The stock has traded between $12.56 and $31.00 over the past 52 weeks. Despite a market cap of $2.0 billion, the company remains unprofitable with a trailing twelve-month EPS of -1.10. The recent insider purchases and the company’s Q1 earnings beat, where it reported EPS of $0.27 above the $0.32 estimate, add to the stock’s momentum. The stock’s beta of 1.65 indicates it is more volatile than the broader market.

What To Watch

Investors should monitor the company’s upcoming earnings report on May 4, 2026, as well as the August 6, 2026, conference call for further insights into its financial performance and business outlook.